Corindus Vascular Robotics Gains FDA Clearance for Next Generation Robotic System

Corindus Vasculat Robotics has received 510(k) clearance from the FDA for its CorPath GRX, the second generation of its CorPath Vascular Robotic System.

The device’s advanced features include active guide management, which enables control of the guide catheter along with robotic control of the guidewire and balloon or stent catheter, with one-millimeter advancement, from the control console.

CorPath GRX will be on display at the Transcatheter Cardiovascular Therapeutics 2016 conference. — Cynthia Jessup